{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:49:01Z","timestamp":1791359341693,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ijcard.2024.132197","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T07:10:39Z","timestamp":1717139439000},"page":"132197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical outcomes of adjusted-dose versus standard-dose prasugrel in East Asian patients with acute myocardial infarction"],"prefix":"10.1016","volume":"410","author":[{"given":"Satoshi","family":"Honda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangyeub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Takegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Nishihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunao","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Asaumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morimasa","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Sun","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Kuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngkeun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.132197_bb0005","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2016","key":"10.1016\/j.ijcard.2024.132197_bb0010","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"152","author":"Levine","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"2023","key":"10.1016\/j.ijcard.2024.132197_bb0015","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132197_bb0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrcardio.2014.104","article-title":"Expert consensus document: world heart federation expert consensus statement on antiplatelet therapy in east Asian patients with ACS or undergoing PCI","volume":"11","author":"Levine","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132197_bb0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0040-1718729","article-title":"The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","volume":"121","author":"Kim","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2024.132197_bb0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-009-0737-1","article-title":"The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects, Japanese","volume":"66","author":"Small","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2024.132197_bb0035","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1253\/circj.CJ-13-1482","article-title":"Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study","volume":"78","author":"Saito","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2024.132197_bb0040","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1253\/circj.CJ-14-0266","article-title":"Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention","volume":"78","author":"Isshiki","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2024.132197_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10557-018-6839-1","article-title":"Rationale, design, and baseline characteristics of the prospective Japan Acute Myocardial Infarction Registry (JAMIR)","volume":"33","author":"Honda","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2024.132197_bb0050","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1253\/circj.CJ-19-0145","article-title":"JAMIR Investigators, contemporary antiplatelet therapy and clinical outcomes of Japanese patients with acute myocardial infarction - results from the prospective Japan Acute Myocardial Infarction Registry (JAMIR)","volume":"83","author":"Yasuda","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2024.132197_bb0055","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1253\/circj.CJ-16-0061","volume":"80","author":"Kim","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2024.132197_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in myocardial infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132197_bb0065","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Academic research consortium, clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2024.132197_bb0070","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N","volume":"361","author":"Wallentin","year":"2009","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.132197_bb0075","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO study","volume":"79","author":"Goto","year":"2015","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2024.132197_bb0080","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/CIRCULATIONAHA.119.041766","article-title":"Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized clinical trial","volume":"140","author":"Park","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2024.132197_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jjcc.2017.05.003","article-title":"Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization","volume":"71","author":"Park","year":"2018","journal-title":"J. Cardiol."},{"issue":"2020","key":"10.1016\/j.ijcard.2024.132197_bb0090","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4070\/kcj.2020.0196","article-title":"Korean society of myocardial infarction expert consensus document on pharmacotherapy for acute myocardial infarction","volume":"50","author":"Kim","year":"2020","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.ijcard.2024.132197_bb0095","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1160\/TH15-05-0366","article-title":"Influence of platelet reactivity on BARC classification in east Asian patients undergoing percutaneous coronary intervention. Results of the ACCEL-BLEED study","volume":"115","author":"Kwon","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2024.132197_bb0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132197_bb0105","first-page":"202","article-title":"Ethnic difference of thrombogenicity in patients with cardiovascular disease: a Pandora box to explain prognostic differences, Korean","volume":"51","author":"Kim","year":"2021","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2024.132197_bb0110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.thromres.2011.11.023","article-title":"Pharmacodynamic assessment of a novel P2Y12 receptor antagonist in Japanese patients with coronary artery disease undergoing elective percutaneous coronary intervention","volume":"129","author":"Yokoi","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2024.132197_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jjcc.2015.07.019","article-title":"Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study","volume":"68","author":"Ogawa","year":"2016","journal-title":"J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324008192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324008192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T06:41:13Z","timestamp":1728110473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324008192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":23,"alternative-id":["S0167527324008192"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132197","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of adjusted-dose versus standard-dose prasugrel in East Asian patients with acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"132197"}}